Home / Companies / Industries / Biotechnology and Drugs / Sucampo Pharmaceuticals, Inc. Overview
Sucampo Pharmaceuticals, Inc. Overview
State:MarylandCountry:United States
Industry:Biotechnology and Drugs
Description:
Sucampo Pharmaceuticals, Inc. is an international biopharmaceutical company focused on the discovery, development and commercialization of drugs based on prostones, a class of compounds occurring naturally in the human body by enzymic (15-hydroxyprostaglandin dehydrogenase (PGDH)) transformation of certain fatty acids. The Company is focused on developing prostone-based compounds for the treatment of gastrointestinal, ocular, vascular, and respiratory diseases and disorders. As of December 31, 2009, two of the Company’s prostone products had received marketing approval. Amitiza (lubiprostone) is a United States Food and Drug Administration (FDA)-approved treatment for chronic idiopathic constipation (CIC) in adults of both genders and all ages, and irritable bowel syndrome with constipation (IBS-C) in adult women. Rescula... (More)
Get Trial Access to OneSource
Company profiles, executive contacts, industry research, and news for sales, marketing and research professionals.
Business Information
Executive Profiles
Company Lists
Disclaimer: While the OneSource Subscription Service maintains the freshest, most
accurate data possible, this free site is refreshed on a periodic basis and may
occasionally contain information that is not current. If you would like to alert
us to a change, please email
us, and we will take steps to make sure your update is included as soon
as possible